top of page

News / Insights
News & Blog
Regulatory updates. Practical perspectives.
A clearer view of what comes next.
Blog: Blog2


FDA Sunscreen Ingredient Update: Bemotrizinol Added to the U.S. OTC Monograph
The First New FDA Sunscreen Ingredient Addition in More Than 20 Years The U.S. Food and Drug Administration (FDA) has added bemotrizinol to the list of permitted sunscreen active ingredients, marking the first new FDA sunscreen ingredient addition to the OTC sunscreen monograph since the late 1990s. The decision represents an important regulatory milestone for the U.S. sunscreen industry and may create new opportunities for product innovation in the years ahead. What Is Bemot
Provision Consulting Group
Jun 232 min read


Grateful for 2025 | Supporting Your 2026 FDA Regulatory Success with a Special Credit
Dear Valued Partners and Clients, As 2025 comes to a close, we look back on a year where the U.S. FDA regulatory landscape was more dynamic than ever—from the full-scale implementation of MoCRA to the restructuring of OTC regulations and the tightening of FSVP management. We would like to express our deepest gratitude to you for choosing Provision Consulting Group as your trusted partner during these rapidly changing times. Top 3 FDA Regulatory Updates of 2025 Here is a summa
Provision Consulting Group
Dec 31, 20252 min read


What’s Changing in U.S. Sunscreen (OTC) Regulations? Key Points of the FDA M020 Update
In the United States, sunscreens are regulated as OTC (Over-the-Counter) drugs , not cosmetics. This means they are subject to strict regulatory frameworks governing everything from ingredients and SPF testing to labeling and safety standards. Recent FDA announcements do not necessarily mean an immediate overhaul of all existing rules. Instead, they signal a strategic update to OTC Monograph M020 , clarifying the standards and direction for future sunscreen regulations. How i
Provision Consulting Group
Dec 22, 20253 min read
From insight to action
What does this mean for your business?
Talk through your FDA questions with a team that stays close to the details.
bottom of page
.png)






































































![[Cosmoprof Miami 2026] K-Beauty: Moving Beyond ‘Registration’ to ‘Regulatory Strategy’](https://static.wixstatic.com/media/7ffba2_1e65dd530d614e1f873c779be2f6a3cb~mv2.png/v1/fill/w_333,h_250,fp_0.50_0.50,q_35,blur_30,enc_avif,quality_auto/7ffba2_1e65dd530d614e1f873c779be2f6a3cb~mv2.webp)
![[Cosmoprof Miami 2026] K-Beauty: Moving Beyond ‘Registration’ to ‘Regulatory Strategy’](https://static.wixstatic.com/media/7ffba2_1e65dd530d614e1f873c779be2f6a3cb~mv2.png/v1/fill/w_172,h_129,fp_0.50_0.50,q_95,enc_avif,quality_auto/7ffba2_1e65dd530d614e1f873c779be2f6a3cb~mv2.webp)